Rafarma Pharmaceuticals

(OTC) RAFA

Current Price$0.05

Market Cap$5.58M

Since IPO (2012)-98%

5 Year-97%

1 Year-31%

1 Month-11%

Rafarma Pharmaceuticals Financials at a Glance

Market Cap

$5.58M

Revenue (TTM)

$9.14M

Net Income (TTM)

$306.00K

EPS (TTM)

$0.00

P/E Ratio

17.11

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$0.05

Volume

45,459

Open

$0.06

Price

$0.05

Volume

45,459

Open

$0.06

Previous Close

$0.06

Daily Range

$0.05 - $0.06

52-Week Range

$0.00 - $0.15

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$0.05

Volume

45,459

Open

$0.06

Previous Close

$0.06

Daily Range

$0.05 - $0.06

52-Week Range

$0.00 - $0.15

RAFA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rafarma Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

CEO

Raivo Unt

Website

www.rafarma.com

Headquarters

Sandy, UT 84070, US

RAFA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

5.84%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.58M

Shares Outstanding

93.17M

Volume

45.46K

Avg. Volume

17.49K

Financials (TTM)

Gross Profit

$761.00K

Operating Income

$489.00K

EBITDA

$489.00K

Operating Cash Flow

$112.00K

Capital Expenditure

$128.00K

Free Cash Flow

$16.00K

Cash & ST Invst.

$58.00K

Total Debt

$23.00K

Rafarma Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$278.00K

+26.4%

Gross Profit

$119.00K

+63.0%

Gross Margin

42.81%

N/A

Market Cap

$5.58M

N/A

Market Cap/Employee

$7.97K

N/A

Employees

700

N/A

Net Income

$74.00K

+117.6%

EBITDA

$92.00K

+19.8%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$77.00K

+16.7%

Accounts Receivable

$1.62M

-13.8%

Inventory

$156.00K

+67.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

1.84%

N/A

Return on Invested Capital

3.47%

N/A

Free Cash Flow

$1.00K

-100.6%

Operating Cash Flow

$1.00K

-100.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RVVTFRevive Therapeutics Ltd.

RVVTFRevive Therapeutics Ltd.$0.02-1.87%

LMLLFPharmadrug Inc.

LMLLFPharmadrug Inc.$0.01-15.80%

LVVVLiveWire Ergogenics, Inc.

LVVVLiveWire Ergogenics, Inc.$0.00+0.00%

IGPKIntegrated Cannabis Solutions, Inc.

IGPKIntegrated Cannabis Solutions, Inc.$0.00-0.00%

UBQUUbiquitech Software Corp.

UBQUUbiquitech Software Corp.$0.00+0.00%

TNRGThunder Energies Corporation

TNRGThunder Energies Corporation$0.00+0.00%

RDDTFRadient Technologies Inc.

RDDTFRadient Technologies Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.40-0.00%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$6.82-0.09%

MARAMara Holdings

MARAMara Holdings$13.53+0.05%

NOKNokia

NOKNokia$13.89+0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.83+0.08%

NVDANvidia

NVDANvidia$219.28+0.02%

INTCIntel

INTCIntel$129.37+0.04%

Questions About RAFA

What is the current price of Rafarma Pharmaceuticals?

Rafarma Pharmaceuticals is trading at $0.05 per share.

What is the 52-week range for Rafarma Pharmaceuticals?

Over the past 52 weeks, Rafarma Pharmaceuticals has traded between $0.00 and $0.15.

How much debt does Rafarma Pharmaceuticals have?

As of the most recent reporting period, Rafarma Pharmaceuticals reported total debt of N/A.

How much cash does Rafarma Pharmaceuticals have on hand?

Rafarma Pharmaceuticals reported $77,000 in cash and cash equivalents in its most recent financial results.

What is Rafarma Pharmaceuticals’s dividend yield?

Rafarma Pharmaceuticals does not currently have a dividend yield.

Rafarma Pharmaceuticals

Rafarma Pharmaceuticals Financials at a Glance

RAFA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Rafarma Pharmaceuticals

RAFA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Rafarma Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RAFA

What is the current price of Rafarma Pharmaceuticals?

What is the 52-week range for Rafarma Pharmaceuticals?

How much debt does Rafarma Pharmaceuticals have?

How much cash does Rafarma Pharmaceuticals have on hand?

What is Rafarma Pharmaceuticals’s dividend yield?

Premium Investing Services